- Home
- AEON vs ATCH Comparison
AEON vs ATCH Comparison
Compare AEON & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- ATCH
- Stock Information
- Founded
- AEON N/A
- ATCH 2022
- Country
- AEON United States
- ATCH United States
- Employees
- AEON N/A
- ATCH N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- AEON Health Care
- ATCH
- Exchange
- AEON Nasdaq
- ATCH Nasdaq
- Market Cap
- AEON 4.2M
- ATCH 3.4M
- IPO Year
- AEON N/A
- ATCH N/A
- Fundamental
- Price
- AEON $0.46
- ATCH $0.43
- Analyst Decision
- AEON Strong Buy
- ATCH
- Analyst Count
- AEON 1
- ATCH 0
- Target Price
- AEON $360.00
- ATCH N/A
- AVG Volume (30 Days)
- AEON 465.0K
- ATCH 653.2K
- Earning Date
- AEON 05-13-2025
- ATCH 05-27-2025
- Dividend Yield
- AEON N/A
- ATCH N/A
- EPS Growth
- AEON N/A
- ATCH N/A
- EPS
- AEON 72.93
- ATCH 2.67
- Revenue
- AEON N/A
- ATCH N/A
- Revenue This Year
- AEON N/A
- ATCH N/A
- Revenue Next Year
- AEON N/A
- ATCH N/A
- P/E Ratio
- AEON $0.01
- ATCH $0.16
- Revenue Growth
- AEON N/A
- ATCH N/A
- 52 Week Low
- AEON $0.38
- ATCH $0.42
- 52 Week High
- AEON $402.48
- ATCH $84.00
- Technical
- Relative Strength Index (RSI)
- AEON 26.87
- ATCH 29.33
- Support Level
- AEON $0.38
- ATCH $0.48
- Resistance Level
- AEON $0.43
- ATCH $0.60
- Average True Range (ATR)
- AEON 0.04
- ATCH 0.07
- MACD
- AEON 0.20
- ATCH 0.08
- Stochastic Oscillator
- AEON 56.29
- ATCH 5.90
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.